These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30854117)

  • 1. Efficacy and Toxicity of IMRT-Based Simultaneous Integrated Boost for the Definitive Management of Positive Lymph Nodes in Patients with Cervical Cancer.
    Dang YZ; Li P; Li JP; Zhang Y; Zhao LN; Li WW; Wei LC; Shi M
    J Cancer; 2019; 10(5):1103-1109. PubMed ID: 30854117
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous integrated or sequential boost to clinically involved lymph nodes in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy.
    Kahvecioglu A; Gurlek E; Yedekci FY; Sari SY; Gultekin M; Yildiz F
    Gynecol Oncol; 2023 Sep; 176():10-15. PubMed ID: 37413947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
    Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
    Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.
    Macchia G; Cilla S; Deodato F; Legge F; Di Stefano A; Chiantera V; Scambia G; Valentini V; Morganti AG; Ferrandina G
    Br J Radiol; 2015; 88(1055):20150385. PubMed ID: 26388108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
    Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
    Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extended-field intensity modulated radiation therapy and intra-cavitary brachytherapy combined with chemotherapy for stage Ib1-IVa cervical cancer with positive para-aortic lymph nodes].
    Ke GH; Huang X; Huang XW; Liu SP; Wu XH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Sep; 48(9):649-53. PubMed ID: 24332129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Survival and Late Toxicity Associated With Pelvic Intensity Modulated Radiation Therapy (IMRT) for Cervical Cancer Involving CT-Based Positive Lymph Nodes.
    Lei C; Ma S; Huang M; An J; Liang B; Dai J; Wu L
    Front Oncol; 2019; 9():520. PubMed ID: 31275853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended field intensity-modulated radiotherapy plus concurrent nedaplatin treatment in cervical cancer.
    Liu Y; Yu J; Qian L; Zhang H; Ma J
    Oncol Lett; 2016 May; 11(5):3421-3427. PubMed ID: 27123128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies.
    Boyle J; Craciunescu O; Steffey B; Cai J; Chino J
    Gynecol Oncol; 2014 Nov; 135(2):239-43. PubMed ID: 25192879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
    Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
    Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the therapeutic effect of synchronous integrated intensity modulated radiotherapy combined with chemotherapy in stage IIIc of cervical cancer.
    Mu Y; Wang H; Xu L; Shi L; Song R; Wang D; Gao Y; Yan H
    Front Oncol; 2024; 14():1283991. PubMed ID: 38884092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-Escalated Intensity-Modulated Radiotherapy for the Management of Locally Advanced Cervical Cancer.
    Shewalkar B; Khan A; Yerlekar D; Patel J; Khadilkar H; Sakthivel R; Kataruka R
    Cureus; 2022 Jun; 14(6):e25965. PubMed ID: 35855254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 1/2 study of hypofractionated intensity-modulated radiation therapy for prostate cancer including simultaneously integrated boost.
    Chang MG; Mukhopadhyay N; Holdford D; Skinner V; Saraiya S; Moghanaki D; Anscher MS
    Pract Radiat Oncol; 2018; 8(3):e149-e157. PubMed ID: 29290572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial.
    Ricco A; Mukhopadhyay N; Deng X; Holdford D; Skinner V; Saraiya S; Moghanaki D; Anscher MS; Chang MG
    Front Oncol; 2020; 10():1686. PubMed ID: 32974208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
    Marnitz S; Köhler C; Burova E; Wlodarczyk W; Jahn U; Grün A; Budach V; Stromberger C
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e137-43. PubMed ID: 21600704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided intensity-modulated radiotherapy in patients with FIGO IIIC1 cervical cancer: efficacy, toxicity and prognosis.
    Meng Q; Liu X; Hu K; Hou X; Zhang F; Wang W; Yan J; Yang B; Li W
    J Cancer; 2023; 14(6):1001-1010. PubMed ID: 37151392
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary results of simultaneous integrated boost intensity-modulated radiation therapy based neoadjuvant chemoradiotherapy on locally advanced rectal cancer with clinically suspected positive lateral pelvic lymph nodes.
    Geng JH; Zhang YZ; Li YH; Li S; Wang L; Wang ZL; Zhu XG; Bu ZD; Li ZY; Su XQ; Cai Y; Wu AW; Wang WH
    Ann Transl Med; 2021 Feb; 9(3):217. PubMed ID: 33708844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate--first results of the PLATIN 1 trial.
    Habl G; Katayama S; Uhl M; Kessel KA; Edler L; Debus J; Herfarth K; Sterzing F
    BMC Cancer; 2015 Nov; 15():868. PubMed ID: 26547188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.